Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin

Wednesday, April 3, 2019 - 06:00 in Health & Medicine

Drug makers, insurers and pharmacy benefit managers face mounting pressure from Congress and the public to reduce the high list prices of drugs like insulin.

Read the whole article on NY Times Science

More from NY Times Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net